{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:41:10Z","timestamp":1790102470733,"version":"4.0.1"},"reference-count":55,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>This is a short review of the basic molecular mechanisms of ovarian aging, written with a particular focus on the use of this data to improve the diagnostic and therapeutic protocols both for women affected by physiological (age-related) ovarian decay and for those suffering premature ovarian insufficiency. Ovarian aging has a genetic basis that conditions the ovarian activity via a plethora of cell-signaling pathways that control the functions of different types of cells in the ovary. There are various factors that can influence these pathways so as to reduce their efficiency. Oxidative stress, often related to mitochondrial dysfunction, leading to the apoptosis of ovarian cells, can be at the origin of vicious circles in which the primary cause feeds back other abnormalities, resulting in an overall decline in the ovarian activity and in the quantity and quality of oocytes. The correct diagnosis of the molecular mechanisms involved in ovarian aging can serve to design treatment strategies that can slow down ovarian decay and increase the quantity and quality of oocytes that can be obtained for an in vitro fertilization attempt. The available treatment options include the use of antioxidants, melatonin, growth hormones, and mitochondrial therapies. All of these treatments have to be considered in the context of each couple\u2019s history and current clinical condition, and a customized (patient-tailored) treatment protocol is to be elaborated.<\/jats:p>","DOI":"10.3390\/ijms22031371","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T11:34:33Z","timestamp":1611920073000},"page":"1371","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Ovarian Aging: Molecular Mechanisms and Medical Management"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4645-5804","authenticated-orcid":false,"given":"Jan","family":"Tesarik","sequence":"first","affiliation":[{"name":"MARGen Clinic, 18006 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Gal\u00e1n-L\u00e1zaro","sequence":"additional","affiliation":[{"name":"MARGen Clinic, 18006 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Mendoza-Tesarik","sequence":"additional","affiliation":[{"name":"MARGen Clinic, 18006 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.fertnstert.2020.03.034","article-title":"Is there a correlation between paternal age and aneuploidy rate? An analysis of 3,118 embryos derived from young egg donors","volume":"114","author":"Dviri","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","article-title":"The nature of aneuploidy with increasing age of the female partner: A review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening","volume":"101","author":"Franasiak","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.fertnstert.2016.01.025","article-title":"Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening","volume":"105","author":"Demko","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cge.12921","article-title":"Genetics of primary ovarian insufficiency","volume":"91","author":"Rossetti","year":"2017","journal-title":"Clin. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"590660","DOI":"10.3389\/fgene.2020.590660","article-title":"Identification of key genes and potential new biomarkers for ovarian aging: A study based on RNA-sequencing data","volume":"11","author":"Ma","year":"2020","journal-title":"Front. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humupd\/dmz043","article-title":"BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging","volume":"26","author":"Turan","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","article-title":"The variability of female reproductive ageing","volume":"8","author":"Pearson","year":"2002","journal-title":"Hum. Reprod. Update"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/humupd\/dmv036","article-title":"Genetics of primary ovarian insufficiency: New developments and opportunities","volume":"21","author":"Qin","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2020.01.009","article-title":"Single-cell transcriptomic atlas of primate ovarian aging","volume":"180","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11427-012-4355-2","article-title":"An update on primary ovarian insufficiency","volume":"55","author":"Jin","year":"2012","journal-title":"Sci. China Life Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s10815-014-0342-9","article-title":"Genetics of primary ovarian insufficiency: A review","volume":"31","author":"Labarta","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","article-title":"Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: Clinical and molecular genetic study","volume":"364","author":"Luoma","year":"2004","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ajhg.2013.03.007","article-title":"Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrault syndrome","volume":"92","author":"Pierce","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1095\/biolreprod.110.088583","article-title":"Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary","volume":"84","author":"Lim","year":"2011","journal-title":"Biol. Reprod."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1210\/js.2018-00329","article-title":"Mitochondrial protein turnover is critical for granulosa cell proliferation and differentiation in antral follicles","volume":"3","author":"Hoque","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/humupd\/dmw028","article-title":"Ovarian ageing: The role of mitochondria in oocytes and follicles","volume":"22","author":"Boucret","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mikhailova, A.A., Shamanskyi, V., Ushakova, K., Mikhailova, A.G., Oreshkov, S., Knorre, D., Tretiakov, E.O., Zazhytska, M., Lukowski, S.W., and Liou, C.-W. (2020). Risk of mitochondrial deletions is affected by the global secondary structure of the mitochondrial genome. bioRxiv, 603282.","DOI":"10.1101\/603282"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"bvaa064","DOI":"10.1210\/jendso\/bvaa064","article-title":"Estradiol and progesterone levels are related to redox status in the follicular fluid during in vitro fertilization","volume":"4","author":"Pizarro","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_19","first-page":"1438","article-title":"Nongenomic effects of 17 beta-estradiol on maturing human oocytes: Relationship to oocyte developmental potential","volume":"80","author":"Tesarik","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s10815-020-01919-y","article-title":"Novel variants in women with premature ovarian function decline identified via whole-exome sequencing","volume":"37","author":"Tang","year":"2020","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1097\/j.pbj.0000000000000062","article-title":"Premature ovarian insufficiency: Clinical orientations for genetic testing and genetic counseling","volume":"5","author":"Barros","year":"2020","journal-title":"Porto Biomed. J."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Smith, H.L., Stevens, A., Minogue, B., Sneddon, S., Shaw, L., Wood, L., Adeniyi, T., Xiao, H., Lio, P., and Kimber, S.J. (2019). Systems based analysis of human embryos and gene networks involved in cell lineage allocation. BMC Genom., 20.","DOI":"10.1186\/s12864-019-5558-8"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: Antral follicle count versus anti-M\u00fcllerian hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reprod. Biomed. Online"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3389\/fendo.2019.00650","article-title":"The concept of growth hormone deficiency affecting clinical prognosis in IVF","volume":"10","author":"Yovich","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_25","first-page":"1","article-title":"New criteria for the use of growth hormone in the treatment of female infertility: Minireview and a case series","volume":"9","author":"Tesarik","year":"2020","journal-title":"EC Gynaecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/dei066","article-title":"Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone","volume":"20","author":"Tesarik","year":"2005","journal-title":"Hum. Reprod."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e6443","DOI":"10.1097\/MD.0000000000006443","article-title":"The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fendo.2019.00500","article-title":"Use of growth hormone in the IVF treatment of women with poor ovarian reserve","volume":"10","author":"Hart","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"519572","DOI":"10.3389\/fendo.2020.519572","article-title":"The effect of GH administration on oocyte and zygote quality in young women with repeated implantation failure after IVF","volume":"11","author":"Tesarik","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1038\/s41598-020-75107-4","article-title":"Growth hormone alleviates oxidative stress and improves oocyte quality in Chinese women with polycystic ovary syndrome: A randomized controlled trial","volume":"11","author":"Gong","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12020-017-1468-1","article-title":"Oxidative stress in adult growth hormone deficiency: Different plasma antioxidant patterns in comparison with metabolic syndrome","volume":"59","author":"Mancini","year":"2018","journal-title":"Endocrine"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tesarik, J., Yovich, J., and Menezo, Y. (2020). Growth Hormone in Fertility and Infertility: Physiology, Pathology, Diagnosis and Treatment. Front. Endocrinol., in press.","DOI":"10.3389\/978-2-88966-555-6"},{"key":"ref_33","first-page":"555829","article-title":"Melatonin: The first noninvasive causal therapy for both endometriosis and adenomyosis?","volume":"12","author":"Tesarik","year":"2018","journal-title":"J. Gynecol. Women\u2019s Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/humrep\/dez082","article-title":"Melatonin activity and receptor expression in endometrial tissue and endometriosis","volume":"34","author":"Mosher","year":"2019","journal-title":"Hum. Reprod."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.32794\/mr11250077","article-title":"Melatonin attenuates growth factor receptor signaling required for SARS-CoV-2 replication","volume":"3","author":"Tesarik","year":"2020","journal-title":"Melatonin Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tamura, H., Jozaki, M., Tanabe, M., Shirafuta, Y., Mihara, Y., Shinagawa, M., Tamura, I., Maekawa, R., Sato, S., and Taketani, T. (2020). Importance of melatonin in assisted reproductive technology and ovarian aging. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031135"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Budani, M.C., and Tiboni, G.M. (2020). Effects of Supplementation with Natural Antioxidants on Oocytes and Preimplantation Embryos. Antioxidants, 9.","DOI":"10.3390\/antiox9070612"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/09513590.2015.1137095","article-title":"The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve","volume":"32","author":"Gat","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12958-018-0343-0","article-title":"Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: A randomized controlled trial","volume":"16","author":"Xu","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1477-7827-12-112","article-title":"Utility of antioxidants during assisted reproductive techniques: An evidence based review","volume":"12","author":"Agarwal","year":"2014","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/GCO.0000000000000164","article-title":"Oocyte mitochondrial function and reproduction","volume":"27","author":"Babayev","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/rmb2.12230","article-title":"Mitochondrial replacement therapy and assisted reproductive technology: A paradigm shift toward treatment of genetic diseases in gametes or in early embryos","volume":"17","author":"Tachibana","year":"2018","journal-title":"Reprod. Med. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(05)62353-7","article-title":"Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs","volume":"350","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/molehr\/4.3.269","article-title":"Ooplasmic transfer in mature human oocytes","volume":"4","author":"Cohen","year":"1998","journal-title":"Mol. Hum. Reprod."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/humrep\/15.5.1149","article-title":"Chemically and mechanically induced membrane fusion: Non-activating methods for nuclear transfer in mature human oocytes","volume":"15","author":"Tesarik","year":"2000","journal-title":"Hum. Reprod."},{"key":"ref_46","unstructured":"Tesarik, J. (2019). Forty years of in vitro fertilisation: A history of continuous expansion. 40 Years after In Vitro Fertilisation: State of the Art and New Challenges, Cambridge Scholars Publishing."},{"key":"ref_47","unstructured":"Tesarik, J. (2019). Improving oocytes and embryos? Cytoplasmic manipulation in human reproduction. 40 Years after In Vitro Fertilisation: State of the Art and New Challenges, Cambridge Scholars Publishing."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/jrf.0.0780463","article-title":"Activation of nucleolar and extranucleolar RNA synthesis and changes in the ribosomal content of human embryos developing in vitro","volume":"78","author":"Tesarik","year":"1986","journal-title":"J. Reprod. Fertil."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/332459a0","article-title":"Human gene expression first occurs between the four- and eight-cell stages of preimplantation development","volume":"332","author":"Braude","year":"1988","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0012-1606(88)90261-8","article-title":"Early morphological signs of embryonic genome expression in human preimplantation development as revealed by quantitative electron microscopy","volume":"128","author":"Tesarik","year":"1988","journal-title":"Dev. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1242\/dev.105.2.317","article-title":"Involvement of oocyte-coded message in cell differentiation control of early human embryos","volume":"105","author":"Tesarik","year":"1989","journal-title":"Development"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.rbmo.2017.01.013","article-title":"Live birth derived from oocyte spindle transfer to prevent mitochondrial disease","volume":"34","author":"Zhang","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.rbmo.2017.05.014","article-title":"Oocyte spindle transfer for prevention of mitochondrial disease: The question of membrane fusion technique","volume":"35","author":"Tesarik","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"555625","DOI":"10.19080\/JGWH.2017.03.555625","article-title":"Customized assisted reproduction enhancement (CARE) for women with extremely poor ovarian reserve (EPOR)","volume":"3","author":"Tesarik","year":"2017","journal-title":"J. Gynecol. Women Health"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/humrep\/dey063","article-title":"Usefulness of individualized FSH, LH and GH dosing in ovarian stimulation of women with low ovarian reserve","volume":"33","author":"Tesarik","year":"2018","journal-title":"Hum. Reprod."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/3\/1371\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:17:22Z","timestamp":1760159842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/3\/1371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22031371"],"URL":"https:\/\/doi.org\/10.3390\/ijms22031371","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]}}}